Bank & Trust Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
4,373
+121
+3% +$9.76K 0.22% 84
2026
Q1
$368K Buy
4,252
+1,626
+62% +$156K 0.25% 83
2025
Q4
$252K Buy
2,626
+40
+2% +$3.88K 0.18% 84
2025
Q3
$246K Hold
2,586
0.18% 84
2025
Q2
$225K Sell
2,586
-83
-3% -$7.04K 0.18% 86
2025
Q1
$240K Sell
2,669
-47
-2% -$4.21K 0.2% 83
2024
Q4
$217K Sell
2,716
-292
-10% -$25.3K 0.18% 88
2024
Q3
$271K Hold
3,008
0.22% 82
2024
Q2
$237K Buy
+3,008
New +$247K 0.2% 83

Other funds holding MDT

Bank & Trust Company's MDT Position: Q2 2026 in Review

Bank & Trust Company increased its Medtronic (MDT) stake by 2.8% in Q2 2026, buying an estimated $9.76K and bringing the position to 4,373 shares worth $342K. The position accounts for 0.22% of the portfolio, ranked #84.

Bank & Trust Company first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $368K in Q1 2026. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bank & Trust Company held 4,373 shares of Medtronic worth $342K as of Q2 2026.
  • Bank & Trust Company bought 121 Medtronic shares in Q2 2026, an estimated $9.76K.
  • Medtronic made up 0.22% of Bank & Trust Company's portfolio in Q2 2026, its #84 holding.
  • Bank & Trust Company first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's Medtronic position peaked at $368K in Q1 2026.
  • 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.